These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Di Matteo V; Esposito E Curr Drug Targets CNS Neurol Disord; 2003 Apr; 2(2):95-107. PubMed ID: 12769802 [TBL] [Abstract][Full Text] [Related]
5. Role of oxidative stress and antioxidants in neurodegenerative diseases. Rao AV; Balachandran B Nutr Neurosci; 2002 Oct; 5(5):291-309. PubMed ID: 12385592 [TBL] [Abstract][Full Text] [Related]
6. Involvement of Astrocytes and microRNA Dysregulation in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Potential. Bai Y; Su X; Piao L; Jin Z; Jin R Front Mol Neurosci; 2021; 14():556215. PubMed ID: 33815055 [TBL] [Abstract][Full Text] [Related]
7. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Esposito E; Rotilio D; Di Matteo V; Di Giulio C; Cacchio M; Algeri S Neurobiol Aging; 2002; 23(5):719-35. PubMed ID: 12392777 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810 [TBL] [Abstract][Full Text] [Related]
9. The role of glycogen synthase kinase 3 beta in neurodegenerative diseases. Yu H; Xiong M; Zhang Z Front Mol Neurosci; 2023; 16():1209703. PubMed ID: 37781096 [TBL] [Abstract][Full Text] [Related]
10. Are age-related neurodegenerative diseases linked with various types of magnesium depletion? Durlach J; Bac P; Durlach V; Durlach A; Bara M; Guiet-Bara A Magnes Res; 1997 Dec; 10(4):339-53. PubMed ID: 9513930 [TBL] [Abstract][Full Text] [Related]
11. Association between menopausal hormone therapy and risk of neurodegenerative diseases: Implications for precision hormone therapy. Kim YJ; Soto M; Branigan GL; Rodgers K; Brinton RD Alzheimers Dement (N Y); 2021; 7(1):e12174. PubMed ID: 34027024 [TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers. Zhang M; He P; Bian Z Front Mol Neurosci; 2021; 14():685143. PubMed ID: 34421536 [TBL] [Abstract][Full Text] [Related]
13. RNA Sequencing Reveals Small and Variable Contributions of Infectious Agents to Transcriptomes of Postmortem Nervous Tissues From Amyotrophic Lateral Sclerosis, Alzheimer's Disease and Parkinson's Disease Subjects, and Increased Expression of Genes From Disease-Activated Microglia. Bennett JP; Keeney PM; Brohawn DG Front Neurosci; 2019; 13():235. PubMed ID: 30983949 [TBL] [Abstract][Full Text] [Related]
14. Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. Taneva SG; Todinova S; Andreeva T Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762599 [TBL] [Abstract][Full Text] [Related]